Jacob George, MD

Jacob George is a co-founder of ChemomAb. He serves as a full Professor of Cardiology in the School of Medicine at the Hebrew University of Jerusalem. Jacob is the current director of the Heart Center at Kaplan Medical Center in Rehovot. He has published more than 300 research papers and has written and edited several chapters and books. Currently, Prof. George serves on the editorial board of fifteen scientific journals. Most of Prof. George’s research centers on the role of the immune system in various inflammatory disorders, and he has been engaged in promoting a series of pharmaceutical products from the bench into clinical trials. Jacob was also a co-founder of VBL Therapeutics.

Adi Mor, Ph.D

Adi Mor is the co-founder and CEO of ChemomAb since 2011. Adi has extensive knowledge and experience in the fields of immunology, autoimmune and inflammatory diseases and a wide experience in designing, promoting and patenting a novel class of monoclonal antibodies to treat inflammatory and cancer diseases. Adi completed her Ph.D. in Immunology from the Tel Aviv University in the Department of Neurobiochemistry and is a lead author of multiple publications in scientific journals in the fields of immunology and inflammatory disorders.